209 related articles for article (PubMed ID: 15871644)
1. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
Stebbins MR; Kaufman DJ; Lipton HL
J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
3. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
4. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
5. Medication therapy management: 10 years of experience in a large integrated health care system.
Ramalho de Oliveira D; Brummel AR; Miller DB
J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
[TBL] [Abstract][Full Text] [Related]
6. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
[TBL] [Abstract][Full Text] [Related]
7. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
Tseng CW; Brook RH; Keeler E; Mangione CM
JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Medicare modernization act on low-income persons.
Havrda DE; Omundsen BA; Bender W; Kirkpatrick MA
Ann Intern Med; 2005 Oct; 143(8):600-8. PubMed ID: 16230727
[TBL] [Abstract][Full Text] [Related]
9. Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.
Stockl KM; Tjioe D; Gong S; Stroup J; Harada AS; Lew HC
J Manag Care Pharm; 2008; 14(6):532-40. PubMed ID: 18693777
[TBL] [Abstract][Full Text] [Related]
10. Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic.
Phillips SL; Carr-Lopez SM
Am J Hosp Pharm; 1990 May; 47(5):1075-9. PubMed ID: 2337097
[TBL] [Abstract][Full Text] [Related]
11. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit.
Spence MM; Hui R; Chan J
J Manag Care Pharm; 2006 Jun; 12(5):377-82. PubMed ID: 16792444
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
Daniel GW; Malone DC
J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
[TBL] [Abstract][Full Text] [Related]
13. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
14. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
15. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
16. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
17. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
[TBL] [Abstract][Full Text] [Related]
18. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
[TBL] [Abstract][Full Text] [Related]
19. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
Narang AK; Nicholas LH
JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
[TBL] [Abstract][Full Text] [Related]
20. Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist.
Johnson SG
J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S19-25. PubMed ID: 19678723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
